Global Pet Vaccine Market Growth 2025-2031

Publication ID:

LPI05251452

Publication Date:

May 2, 2025

Pages:

130

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pet Vaccine market size is predicted to grow from US$ 4032 million in 2025 to US$ 6176 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.
Pet vaccines are biological preparations designed to stimulate an immune response in pets, protecting them from infectious diseases caused by viruses, bacteria, and other pathogens. These vaccines help prevent severe illnesses such as rabies, distemper, parvovirus, and feline leukemia, reducing mortality rates and improving the overall health of companion animals. Vaccination is a crucial aspect of preventive veterinary care and is commonly administered to dogs, cats, and other domesticated animals based on specific vaccination schedules.
With advancements in veterinary medicine, modern pet vaccines are becoming more effective, safer, and tailored to specific breeds and regional disease risks. Innovations such as recombinant vaccines and mRNA-based vaccines are enhancing immune responses with fewer side effects. As pet ownership rises globally and awareness of animal health increases, the demand for high-quality pet vaccines continues to grow, supporting both public health and animal welfare.
Market Drivers:
The pet vaccine market is primarily driven by the increasing pet ownership worldwide and a growing awareness of animal health and preventive care. As more people adopt pets, the demand for vaccines to protect them from infectious diseases rises, especially with the expansion of the pet care industry. Moreover, advancements in veterinary vaccines, including more effective and safer vaccines, are improving vaccination outcomes and encouraging wider use. Public health initiatives and regulations, such as rabies vaccination requirements, also play a role in fueling market growth. Additionally, rising disposable incomes, particularly in emerging markets, are enabling pet owners to spend more on veterinary care, including vaccinations.
Market Challenges:
One of the major challenges facing the pet vaccine market is the high cost of some vaccines, which can be a barrier to regular vaccination, especially for pet owners in lower-income regions. Furthermore, the increasing complexity of vaccine schedules and the need for specialized veterinary care may slow down adoption rates in some areas. In addition, the emergence of counterfeit or low-quality vaccines poses a significant threat to market growth and animal health. Regulatory barriers and inconsistencies across different regions can also hinder the efficient distribution and accessibility of vaccines, especially in emerging markets with less-developed veterinary infrastructure.
The 鈥淧et Vaccine Industry Forecast鈥� looks at past sales and reviews total world Pet Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Vaccine sales for 2025 through 2031. With Pet Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pet Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pet Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nasal Administration
Injection
Other
Segmentation by Application:
Cat
Dog
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
CAHIC
Ringpu
Jinyu Group
Keqian Biology
Kyoritsu Seiyaku
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet Vaccine market?
What factors are driving Pet Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Vaccine market opportunities vary by end market size?
How does Pet Vaccine break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pet Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pet Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Pet Vaccine Segment by Type
2.2.1 Nasal Administration
2.2.2 Injection
2.2.3 Other
2.3 Pet Vaccine Sales by Type
2.3.1 Global Pet Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Pet Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pet Vaccine Sale Price by Type (2020-2025)
2.4 Pet Vaccine Segment by Application
2.4.1 Cat
2.4.2 Dog
2.4.3 Other
2.5 Pet Vaccine Sales by Application
2.5.1 Global Pet Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Pet Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pet Vaccine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pet Vaccine Breakdown Data by Company
3.1.1 Global Pet Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Pet Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Pet Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Pet Vaccine Revenue by Company (2020-2025)
3.2.2 Global Pet Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Pet Vaccine Sale Price by Company
3.4 Key Manufacturers Pet Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Vaccine Product Location Distribution
3.4.2 Players Pet Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pet Vaccine by Geographic Region
4.1 World Historic Pet Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Pet Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pet Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pet Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Pet Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pet Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pet Vaccine Sales Growth
4.4 APAC Pet Vaccine Sales Growth
4.5 Europe Pet Vaccine Sales Growth
4.6 Middle East & Africa Pet Vaccine Sales Growth
5 Americas
5.1 Americas Pet Vaccine Sales by Country
5.1.1 Americas Pet Vaccine Sales by Country (2020-2025)
5.1.2 Americas Pet Vaccine Revenue by Country (2020-2025)
5.2 Americas Pet Vaccine Sales by Type (2020-2025)
5.3 Americas Pet Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Vaccine Sales by Region
6.1.1 APAC Pet Vaccine Sales by Region (2020-2025)
6.1.2 APAC Pet Vaccine Revenue by Region (2020-2025)
6.2 APAC Pet Vaccine Sales by Type (2020-2025)
6.3 APAC Pet Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Vaccine by Country
7.1.1 Europe Pet Vaccine Sales by Country (2020-2025)
7.1.2 Europe Pet Vaccine Revenue by Country (2020-2025)
7.2 Europe Pet Vaccine Sales by Type (2020-2025)
7.3 Europe Pet Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Vaccine by Country
8.1.1 Middle East & Africa Pet Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pet Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pet Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Pet Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Vaccine
10.3 Manufacturing Process Analysis of Pet Vaccine
10.4 Industry Chain Structure of Pet Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Vaccine Distributors
11.3 Pet Vaccine Customer
12 World Forecast Review for Pet Vaccine by Geographic Region
12.1 Global Pet Vaccine Market Size Forecast by Region
12.1.1 Global Pet Vaccine Forecast by Region (2026-2031)
12.1.2 Global Pet Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pet Vaccine Forecast by Type (2026-2031)
12.7 Global Pet Vaccine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pet Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Pet Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Elanco Animal Health
13.3.1 Elanco Animal Health Company Information
13.3.2 Elanco Animal Health Pet Vaccine Product Portfolios and Specifications
13.3.3 Elanco Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Elanco Animal Health Main Business Overview
13.3.5 Elanco Animal Health Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Pet Vaccine Product Portfolios and Specifications
13.4.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Pet Vaccine Product Portfolios and Specifications
13.5.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Pet Vaccine Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Vaccine Product Portfolios and Specifications
13.7.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Vetoquinol
13.8.1 Vetoquinol Company Information
13.8.2 Vetoquinol Pet Vaccine Product Portfolios and Specifications
13.8.3 Vetoquinol Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Vetoquinol Main Business Overview
13.8.5 Vetoquinol Latest Developments
13.9 Meiji
13.9.1 Meiji Company Information
13.9.2 Meiji Pet Vaccine Product Portfolios and Specifications
13.9.3 Meiji Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Meiji Main Business Overview
13.9.5 Meiji Latest Developments
13.10 Ouro Fino Saude
13.10.1 Ouro Fino Saude Company Information
13.10.2 Ouro Fino Saude Pet Vaccine Product Portfolios and Specifications
13.10.3 Ouro Fino Saude Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ouro Fino Saude Main Business Overview
13.10.5 Ouro Fino Saude Latest Developments
13.11 Animalcare Group
13.11.1 Animalcare Group Company Information
13.11.2 Animalcare Group Pet Vaccine Product Portfolios and Specifications
13.11.3 Animalcare Group Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Animalcare Group Main Business Overview
13.11.5 Animalcare Group Latest Developments
13.12 Parnell
13.12.1 Parnell Company Information
13.12.2 Parnell Pet Vaccine Product Portfolios and Specifications
13.12.3 Parnell Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Parnell Main Business Overview
13.12.5 Parnell Latest Developments
13.13 CAHIC
13.13.1 CAHIC Company Information
13.13.2 CAHIC Pet Vaccine Product Portfolios and Specifications
13.13.3 CAHIC Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 CAHIC Main Business Overview
13.13.5 CAHIC Latest Developments
13.14 Ringpu
13.14.1 Ringpu Company Information
13.14.2 Ringpu Pet Vaccine Product Portfolios and Specifications
13.14.3 Ringpu Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Ringpu Main Business Overview
13.14.5 Ringpu Latest Developments
13.15 Jinyu Group
13.15.1 Jinyu Group Company Information
13.15.2 Jinyu Group Pet Vaccine Product Portfolios and Specifications
13.15.3 Jinyu Group Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jinyu Group Main Business Overview
13.15.5 Jinyu Group Latest Developments
13.16 Keqian Biology
13.16.1 Keqian Biology Company Information
13.16.2 Keqian Biology Pet Vaccine Product Portfolios and Specifications
13.16.3 Keqian Biology Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Keqian Biology Main Business Overview
13.16.5 Keqian Biology Latest Developments
13.17 Kyoritsu Seiyaku
13.17.1 Kyoritsu Seiyaku Company Information
13.17.2 Kyoritsu Seiyaku Pet Vaccine Product Portfolios and Specifications
13.17.3 Kyoritsu Seiyaku Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Kyoritsu Seiyaku Main Business Overview
13.17.5 Kyoritsu Seiyaku Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂